Search research articles
Contact Us
Filters
Showing results (271-280 of 301) with videos related to
Page
of 31
Sort By:
The Lancet. Oncology
|
January 17, 2022
Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial
Howard P Safran, Kathryn Winter, David H Ilson, et al.
American Journal of Clinical Oncology
|
January 28, 2020
Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical Trial
Ross A Abrams, Kathryn A Winter, Howard Safran, et al.
Clinical and Translational Radiation Oncology
|
February 16, 2026
Late toxicity after peposertib-enhanced chemoradiation in rectal cancer patients managed with organ preservation
W Zambare, R Ravella, C Li, et al.
Advances in Radiation Oncology
|
June 16, 2018
Postresection CA19-9 and margin status as predictors of recurrence after adjuvant treatment for pancreatic carcinoma: Analysis of NRG oncology RTOG trial 9704
William F Regine, Kathryn Winter, Ross A Abrams, et al.
JAMA Oncology
|
December 19, 2024
Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma: The NRG Oncology/RTOG 1112 Phase 3 Randomized Clinical Trial
Laura A Dawson, Kathryn A Winter, Jennifer J Knox, et al.
JAMA Oncology
|
March 23, 2018
Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Andrea Cercek, Campbell S D Roxburgh, Paul Strombom, et al.
The Journal of Clinical Investigation
|
March 12, 2014
Transport properties of pancreatic cancer describe gemcitabine delivery and response
Eugene J Koay, Mark J Truty, Vittorio Cristini, et al.
Annals of Surgery
|
March 13, 2013
Optimal management of gastric cancer: results from an international RAND/UCLA expert panel
Natalie Coburn, Rajini Seevaratnam, Lawrence Paszat, et al.
Surgery
|
October 1, 2013
What provider volumes and characteristics are appropriate for gastric cancer resection? Results of an international RAND/UCLA expert panel
Matthew Dixon, Alyson Mahar, Lawrence Paszat, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 3, 2019
Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma
Awalpreet S Chadha, Jillian R Gunther, Cheng-En Hsieh, et al.
Page
of 31
Search research articles
Search
Showing results (271-280 of 301) with videos related to
Sort By:
Page
of 31
The Lancet. Oncology
|
January 17, 2022
Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial
Howard P Safran, Kathryn Winter, David H Ilson, et al.
American Journal of Clinical Oncology
|
January 28, 2020
Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical Trial
Ross A Abrams, Kathryn A Winter, Howard Safran, et al.
Clinical and Translational Radiation Oncology
|
February 16, 2026
Late toxicity after peposertib-enhanced chemoradiation in rectal cancer patients managed with organ preservation
W Zambare, R Ravella, C Li, et al.
Advances in Radiation Oncology
|
June 16, 2018
Postresection CA19-9 and margin status as predictors of recurrence after adjuvant treatment for pancreatic carcinoma: Analysis of NRG oncology RTOG trial 9704
William F Regine, Kathryn Winter, Ross A Abrams, et al.
JAMA Oncology
|
December 19, 2024
Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma: The NRG Oncology/RTOG 1112 Phase 3 Randomized Clinical Trial
Laura A Dawson, Kathryn A Winter, Jennifer J Knox, et al.
JAMA Oncology
|
March 23, 2018
Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Andrea Cercek, Campbell S D Roxburgh, Paul Strombom, et al.
The Journal of Clinical Investigation
|
March 12, 2014
Transport properties of pancreatic cancer describe gemcitabine delivery and response
Eugene J Koay, Mark J Truty, Vittorio Cristini, et al.
Annals of Surgery
|
March 13, 2013
Optimal management of gastric cancer: results from an international RAND/UCLA expert panel
Natalie Coburn, Rajini Seevaratnam, Lawrence Paszat, et al.
Surgery
|
October 1, 2013
What provider volumes and characteristics are appropriate for gastric cancer resection? Results of an international RAND/UCLA expert panel
Matthew Dixon, Alyson Mahar, Lawrence Paszat, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 3, 2019
Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma
Awalpreet S Chadha, Jillian R Gunther, Cheng-En Hsieh, et al.
Page
of 31